Page last updated: 2024-08-23

nicorandil and Pulmonary Hypertension

nicorandil has been researched along with Pulmonary Hypertension in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, HW; Chen, YL; Chua, S; Chung, SY; Hsu, SY; Lee, FY; Leu, S; Lu, HI; Sheu, JJ; Sun, CK; Tsai, TH; Yip, HK; Zhen, YY1
Fukayama, T; Fukushima, R; Goya, S; Nakata, TM; Tanaka, R; Yoshiyuki, R1
Babelova, A; Brandes, RP; Buerkl, J; Hofstetter, C; Kirschning, T; Mieth, A; Neofitidou, S; Revermann, M; Schermuly, RT; Schloss, M; Schröder, K1
Hirata, Y; Morita, T; Nagai, R; Sahara, M; Sata, M1
Bi, LQ; Cao, Q; Wang, H; Wang, Q; Xie, WP; Yu, YZ; Zuo, XR1
Hongo, M; Ikeda, U; Kinoshita, O; Koizumi, T; Mawatari, E; Ruan, Z; Sakai, A; Shibamoto, T; Terasawa, F; Yazaki, Y1
Hirata, Y; Imai, Y; Morita, T; Nagai, R; Nakajima, T; Sahara, M; Takahashi, T; Yao, A1

Reviews

1 review(s) available for nicorandil and Pulmonary Hypertension

ArticleYear
New insights in the treatment strategy for pulmonary arterial hypertension.
    Cardiovascular drugs and therapy, 2006, Volume: 20, Issue:5

    Topics: Anticoagulants; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nicorandil; Nitric Oxide Donors; Oxygen Inhalation Therapy; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyridazines; Sildenafil Citrate; Sulfones; Vasodilator Agents

2006

Trials

1 trial(s) available for nicorandil and Pulmonary Hypertension

ArticleYear
Levosimendan attenuates pulmonary vascular remodeling.
    Intensive care medicine, 2011, Volume: 37, Issue:8

    Topics: Airway Remodeling; Animals; Cardiotonic Agents; Disease Models, Animal; Germany; Glyburide; Hydrazones; Hypertension, Pulmonary; Hypoglycemic Agents; Myocardial Contraction; Nicorandil; Potassium Channels; Pulmonary Circulation; Pyridazines; Rats; Rats, Sprague-Dawley; Simendan; Vasodilator Agents

2011

Other Studies

5 other study(ies) available for nicorandil and Pulmonary Hypertension

ArticleYear
Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2013, Nov-20, Volume: 50, Issue:3-4

    Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; bcl-2-Associated X Protein; Caspase 3; Cell Cycle Checkpoints; Cell Line; Colchicine; Connexin 43; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Heart Ventricles; Hypertension, Pulmonary; Lung; Male; Matrix Metalloproteinase 9; Monocrotaline; Myocytes, Smooth Muscle; NF-kappa B; Nicorandil; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Smad3 Protein; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1

2013
Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.
    Journal of cardiovascular pharmacology, 2015, Volume: 65, Issue:6

    Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Nicorandil; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 5 Inhibitors; Pyridazines; Rats, Wistar; Recovery of Function; Severity of Illness Index; Sildenafil Citrate; Vasodilator Agents; Ventricular Dysfunction, Right; Ventricular Function, Right

2015
Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
    PloS one, 2012, Volume: 7, Issue:3

    Topics: Animals; Antihypertensive Agents; Apoptosis; Blotting, Western; Caspase 3; Cells, Cultured; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Familial Primary Pulmonary Hypertension; Glyburide; Human Umbilical Vein Endothelial Cells; Humans; Hypertension, Pulmonary; Injections, Intraperitoneal; Male; MAP Kinase Signaling System; Monocrotaline; NG-Nitroarginine Methyl Ester; Nicorandil; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Pressure

2012
Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Animals; Antihypertensive Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Hypertension, Pulmonary; In Situ Nick-End Labeling; Natriuretic Peptide, Brain; Nicorandil; Proto-Oncogene Proteins c-bcl-2; Rats; Ventricular Remodeling

2012
Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats.
    Journal of cardiovascular pharmacology, 2005, Volume: 46, Issue:4

    Topics: Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Blotting, Western; Endothelium, Vascular; Follow-Up Studies; Heart Rate; Hypertension, Pulmonary; Immunohistochemistry; Leukocyte Common Antigens; Male; Monocrotaline; Nicorandil; Nitric Oxide Synthase; P-Selectin; Proliferating Cell Nuclear Antigen; Pulmonary Artery; Random Allocation; Rats; Rats, Sprague-Dawley; Vasodilator Agents

2005